Federal agencies are investigating illnesses tied to injectable glutathione made with an ingredient labeled "dietary supplement grade." Brock walks through the recalls, what the FDA and CDC have said so far, and a quick pharmacy-enforcement update.
Read the full post: Contaminated glutathione injections: what the endotoxin recalls show
In this episode
- 00:00 Cold open
- 00:11 The glutathione recalls
- 01:22 What the CDC and FDA have confirmed
- 02:00 Quick hits: a pharmacy warning letter and the sport rules
- 02:35 What this means for you
Peptides covered
Sources
- Victory Medical Center Pharmacy issues voluntary nationwide recall of certain lots of compounded glutathione — U.S. FDA, August 5, 2026. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/victory-medical-center-pharmacy-issues-voluntary-nationwide-recall-certain-lots-compounded
- FDA reminds compounders not to use dietary supplement grade glutathione in injectables — U.S. FDA, August 27, 2026. https://www.fda.gov/drugs/human-drug-compounding/fda-reminds-compounders-not-use-dietary-supplement-grade-glutathione-injectables
- Current situation: illnesses linked to glutathione injections — CDC, updated September 15, 2026. https://www.cdc.gov/healthcare-associated-infections/current-situation/index.html
- FDA Empower Pharmacy warning letter, GLP-1 and CGMP compliance — Maven Regulatory Solutions, September 30, 2026. https://www.mavenrs.com/fda-empower-pharmacy-warning-letter-glp1-cgmp-compliance-2026
Educational information, not medical advice.